The Efficacy of Ultrasound-guided Ozone Injection in the Treatment of Patients With Chronic Low Back Pain
Unknown statusNot applicableNCT05586633
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Low back pain is a common disorder that every individual in the society is likely to meet throughout his/her life. Low back pain lasting longer than 12 weeks is defined as chronic low back pain and causes serious disability in the community. Conservative, pharmacological, interventional and surgical treatment options are available in its treatment. In this study, it was aimed to determine the effects of ultrasound-guided deep paravertebral periforaminal ozone injection treatment on physical examination, functional independence, quality of life and pain scores in patients with chronic low back and leg pain and to compare it with transforaminal epidural steroid injection treatment.
Study details
- Official title
- The Efficacy of Ultrasound-guided Deep Paravertebral-periforaminal Ozone Injection in the Treatment of Patients With Chronic Low Back Pain
- Conditions
- Low Back Pain, Posterior Compartment
- Interventions
- Procedure: deep paravertebral periforaminal ozone injeciton
- Procedure: transforaminal steroid injeciton
- Sponsor
- Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
- Start date
- 2021-11-01
- Primary completion
- 2022-11-01
- Sex
- All
- Age range
- from 20 Years to 70 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Back and leg pain lasting longer than 3 months * Diagnosis of lumbar disc herniation with advanced imaging techniques after anamnesis, - physical examination and laboratory examinations * Continuation of complaints despite conservative treatment before * Regular participation in the study voluntarily Exclusion Criteria: * Being pregnant and breastfeeding * History of lomber surgery * Peripheral neuropathy (diabetes, alcoholism...) * Cauda equina syndrome or progressive neurologic deficit in the lower extremity * Neurogenic bladder/bowel syndrome * Arterial vascular disease-Vascular claudication * Spinal stenosis, spondylolysis, spondylolisthesis * Local infection at the injection site * Presence of bleeding diathesis * Neuro-degenerative diseases * Uncontrolled diabetes, hypertension * History of malignancy * Uncontrolled psychiatric illness * BMI over 40 * Allergy to injection substances
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05586633